Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Treatment Outcome and Immunogenicity of mild-to Moderate COVID-19 Patients During the Delta vs. the Omicron Pandemic

NCT05328479 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT05328479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05328479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Treatment Outcome and Immunogenicity of mild-to Moderate COVID-19 Patients During the Delta vs. the Omicron Pandemic
Lead sponsor
Mahidol University
Phase
Observational
Overall status
Completed
Start date
November 4, 2021
Completion date
May 20, 2022
Enrollment
5,181 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19